ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

0JDK Iovance Biotherapeutics Inc

16.25
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000001.19M
Operating Income -53.64M-92.88M-128.26M-206.87M-261.94M-342.7M-398.88M-460.56M
Pre Tax Income -52.89M-92.06M-123.58M-197.56M-259.58M-342.25M-395.89M-447.52M
Net Income -102.35M-92.06M-123.58M-197.56M-259.58M-342.25M-395.89M-444.04M
Preferred Dividends -49.45M0000000
Basic Earnings Per Share (EPS) -1.644-1.258-1.001-1.517-1.723-2.141-2.076-1.716
EBIT -53.64M-92.88M-128.26M-206.87M-261.94M-342.7M-398.88M-460.56M
EBITDA -52.66M-91.93M-127.3M-205.7M-260.8M-339.59M-389.57M-439.14M